Imvax Appoints Sean Hemingway as Chief Operating Officer
PHILADELPHIA, April 8, 2021 /PRNewswire/ — Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with Glioblastoma (GBM) and other cancers, announced today the appointment of Sean Hemingway as the company’s Chief Operating Officer (COO). Hemingway…
Comments Off on Imvax Appoints Sean Hemingway as Chief Operating Officer